Bovine Adenovirus Vectored Vaccine for Avian Influenza
Copyright policy )Bovine Adenovirus Vectored Vaccine for Avian Influenza
Reports of avian influenza in humans over the past several years have raised concerns about a potential H5N1 influenza pandemic. The development of a vaccine against H5N1 influenza is therefore an important research priority. In this issue of Molecular Therapy, Singh and colleagues1 report the construction of a bovine adenovirus serotype 3 (BAd3)–based vector expressing the hemagglutinin (HA) protein from the H5N1 influenza virus.
- Harvard University United States
- Beth Israel Deaconess Medical Center United States
Pharmacology, Clinical Trials as Topic, Vaccines, Influenza A Virus, H5N1 Subtype, Chemistry, Pharmaceutical, Genetic Vectors, Adenoviridae, Birds, Genetic Techniques, Influenza in Birds, Drug Discovery, Genetics, Molecular Medicine, Animals, Humans, Cattle, Molecular Biology
Pharmacology, Clinical Trials as Topic, Vaccines, Influenza A Virus, H5N1 Subtype, Chemistry, Pharmaceutical, Genetic Vectors, Adenoviridae, Birds, Genetic Techniques, Influenza in Birds, Drug Discovery, Genetics, Molecular Medicine, Animals, Humans, Cattle, Molecular Biology
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).1 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!